ANDREW MURPHY - 15 Nov 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Signature
/s/**Andrew Murphy
Issuer symbol
REGN
Transactions as of
15 Nov 2021
Transactions value $
$-9,813,455
Form type
4
Filing time
17 Nov 2021, 15:04:48 UTC
Next filing
10 Dec 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Gift $0 -1,645 -2.87% $0.000000 55,705 16 Aug 2021 Direct
transaction REGN Common Stock Options Exercise $862,605 +16,579 +29.8% $52.03* 72,284 15 Nov 2021 Direct F1
transaction REGN Common Stock Tax liability $-6,037,798 -9,412 -13% $641.50 62,872 15 Nov 2021 Direct F1
transaction REGN Common Stock Sale $-298,883 -465 -0.74% $642.76 62,407 16 Nov 2021 Direct F1, F2
transaction REGN Common Stock Sale $-594,520 -924 -1.48% $643.42 61,483 16 Nov 2021 Direct F1, F3
transaction REGN Common Stock Sale $-713,049 -1,106 -1.8% $644.71 60,377 16 Nov 2021 Direct F1, F4
transaction REGN Common Stock Sale $-1,058,472 -1,640 -2.72% $645.41 58,737 16 Nov 2021 Direct F1, F5
transaction REGN Common Stock Sale $-360,112 -557 -0.95% $646.52 58,180 16 Nov 2021 Direct F1, F6
transaction REGN Common Stock Sale $-546,397 -844 -1.45% $647.39 57,336 16 Nov 2021 Direct F1, F7
transaction REGN Common Stock Sale $-55,745 -86 -0.15% $648.20 57,250 16 Nov 2021 Direct F1, F8
transaction REGN Common Stock Sale $-3,246 -5 -0.01% $649.26 57,245 16 Nov 2021 Direct F1
transaction REGN Common Stock Sale $-192,820 -296 -0.52% $651.42 56,949 16 Nov 2021 Direct F1, F9
transaction REGN Common Stock Sale $-86,748 -133 -0.23% $652.24 56,816 16 Nov 2021 Direct F1, F10
transaction REGN Common Stock Sale $-296,603 -454 -0.8% $653.31 56,362 16 Nov 2021 Direct F1, F11
transaction REGN Common Stock Sale $-129,559 -198 -0.35% $654.34 56,164 16 Nov 2021 Direct F1, F12
transaction REGN Common Stock Sale $-60,288 -92 -0.16% $655.30 56,072 16 Nov 2021 Direct F1, F13
transaction REGN Common Stock Sale $-48,652 -74 -0.13% $657.46 55,998 16 Nov 2021 Direct F1
transaction REGN Common Stock Sale $-46,758 -71 -0.13% $658.56 55,927 16 Nov 2021 Direct F1
transaction REGN Common Stock Sale $-102,168 -155 -0.28% $659.15 55,772 16 Nov 2021 Direct F1, F14
transaction REGN Common Stock Sale $-44,241 -67 -0.12% $660.32 55,705 16 Nov 2021 Direct F1
holding REGN Common Stock 4,269 15 Nov 2021 By 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -16,579 -50.1% $0.000000 16,500 15 Nov 2021 Common Stock 16,579 $52.03 Direct F1, F15
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 Represents volume-weighted average price of sales of 465 shares of Company stock on November 16, 2021 at prices ranging from $642.35 to $642.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
F3 Represents volume-weighted average price of sales of 924 shares of Company stock on November 16, 2021 at prices ranging from $643.07 to $643.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
F4 Represents volume-weighted average price of sales of 1,106 shares of Company stock on November 16, 2021 at prices ranging from $644.24 to $644.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
F5 Represents volume-weighted average price of sales of 1,640 shares of Company stock on November 16, 2021 at prices ranging from $645.01 to $645.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
F6 Represents volume-weighted average price of sales of 557 shares of Company stock on November 16, 2021 at prices ranging from $646.12 to $646.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
F7 Represents volume-weighted average price of sales of 844 shares of Company stock on November 16, 2021 at prices ranging from $647.09 to $647.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
F8 Represents volume-weighted average price of sales of 86 shares of Company stock on November 16, 2021 at prices ranging from $648.15 to $648.77. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
F9 Represents volume-weighted average price of sales of 296 shares of Company stock on November 16, 2021 at prices ranging from $651.00 to $651.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
F10 Represents volume-weighted average price of sales of 133 shares of Company stock on November 16, 2021 at prices ranging from $652.22 to $652.40. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
F11 Represents volume-weighted average price of sales of 454 shares of Company stock on November 16, 2021 at prices ranging from $653.04 to $653.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
F12 Represents volume-weighted average price of sales of 198 shares of Company stock on November 16, 2021 at prices ranging from $654.07 to $654.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
F13 Represents volume-weighted average price of sales of 92 shares of Company stock on November 16, 2021 at prices ranging from $655.20 to $655.31. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
F14 Represents volume-weighted average price of sales of 155 shares of Company stock on November 16, 2021 at prices ranging from $659.01 to $659.30. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
F15 The stock option award vests in four equal annual installments, commencing one year after the date of grant.